Totalmente de acuerdo con el artículo que añades. No solo por el coste de analizar los falsos positivos en AP, sino por desconocerse el valor de la detección precoz con estos métodos a nivel de población general. Habrá que demostrar su beneficio poblaciona
@eugeniparedes @joaqmorera @je_pala Correcto, pronto habrán datos... Pero yo creo que los tiros van más enfocados a esto: https://t.co/M4isCbakqt Imagina que apple pueda pasar cobro a las aseguradoras como "Holter"... Hay mucho de negocio turbio por ahí.
Very interesting question! Who should pay for reviewing the ECGs from the Apple Watch 4 series? https://t.co/WmRaGqmVrY
RT @pash22: Who shud pay 4 reviewing the ECGs from @Apple Watch 4 series? https://t.co/BdAAj0bVKu via @ranirobson My answer is make Apple…
RT @pash22: Who shud pay 4 reviewing the ECGs from @Apple Watch 4 series? https://t.co/BdAAj0bVKu via @ranirobson My answer is make Apple…
RT @pash22: Who shud pay 4 reviewing the ECGs from @Apple Watch 4 series? https://t.co/BdAAj0bVKu via @ranirobson My answer is make Apple…
RT @ranirobson: Self-screening is going to take off exponentially... In our unique health system, free at the point of access, how are we g…
Who shud pay 4 reviewing the ECGs from @Apple Watch 4 series? https://t.co/BdAAj0bVKu via @ranirobson My answer is make Apple & @AHSNNetwork & @TheBHF & @KnowYourPulse pay for all the false-positives Need to screen 10000 in low prevalence are
Self-screening is going to take off exponentially... In our unique health system, free at the point of access, how are we going to plan for managing the cost implication? @mgtmccartney @petbri https://t.co/MLWN18ahkN